Michael Dale: Chief Executive Officer at Axogen, Inc., stock sales and holdings

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

What the filings show, past 12 months. Nothing here rates or predicts.

Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025.
Largest single sale: $1.9M (61,463 shares) of Axogen, Inc. on Dec 9, 2025. Filing
No sale on record before this period.

Every company we track where this person has filed, newest filing first.

Company	Title	First filing	Latest filing
Axogen, Inc. (AXGN)	Chief Executive Officer	Aug 9, 2024	Feb 27, 2026
Abbott Laboratories (ABT)	Former Senior Vice President	Nov 19, 2019	Mar 2, 2023

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

Dec 10, 2025, Axogen, Inc.: sold 25,000 shares for $750K, no plan disclosed. 1 filing: 1
Dec 9, 2025, Axogen, Inc.: sold 61,463 shares for $1.9M, to cover taxes. 1 filing: 1
Dec 4, 2025, Axogen, Inc.: 150,000 shares awarded. 1 filing: 1

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.